Companies: 10,795·Total market cap: $144.5T
ImpediMed Limited

ImpediMed Limited

IPDQFOTCHealthcare● Active
$0.00
$-0.00(-23.73%)
Market Cap$10527165
P/E Ratio
52W High$0.0514
52W Low$0.0045

ImpediMed Limited(IPDQF)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · IPDQF · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-062024-062023-062022-062021-06
Revenue
Revenue$12.72M$10.05M$11.34M$10.49M$8.35M
Cost of Revenue$1.75M$1.31M$25.00M$1.71M$1.60M
Gross Profit$10.97M$8.74M($13.65M)$8.79M$6.75M
Gross Margin %(computed)86.25%86.93%-120.36%83.72%80.82%
Operating Expenses
R&D Expenses$0.00M$0.22M$0.60M$0.68M$1.46M
G&A Expenses$21.51M$22.09M$19.51M$18.15M$21.42M
Total Operating Expenses$35.21M$33.04M$9.19M$30.32M$29.82M
Operating Income($24.23M)($24.30M)($22.85M)($21.54M)($23.07M)
Operating Margin %(computed)-190.44%-241.76%-201.39%-205.21%-276.22%
Interest Income$0.96M$1.56M$0.80M$0.05M$0.02M
Interest Expense$1.09M$0.09M$0.03M$0.03M$0.05M
Income Before Tax($23.21M)($19.76M)($22.08M)($19.83M)($20.67M)
Income Tax Expense$0.03M$0.03M($1.55M)$0.05M$0.04M
Net Income($23.24M)($19.79M)($20.52M)($19.87M)($20.71M)
Net Margin %(computed)-182.62%-196.86%-180.90%-189.37%-247.89%
Per Share & EBITDA
EPS (Basic)$-0.01$-0.01$-0.01$-0.01$-0.02
Wtd Avg Shares2019.18M2021.74M1800.35M1678.95M1202.32M
EBITDA($17.55M)($22.05M)($20.49M)($18.77M)($21.37M)
EBITDA Margin %(computed)-137.95%-219.35%-180.65%-178.83%-255.87%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · AUD · M

深入了解ImpediMed Limited

关于ImpediMed Limited(IPDQF)损益表

ImpediMed Limited(IPDQF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,IPDQF实现营收$0.01B,毛利润$0.01B(毛利率86.25%),净利润($0.02B)(净利率-182.62%)。

常见问题

IPDQF · 4 问

ImpediMed Limited(IPDQF)2025财年营收为$0.01B,同比up26.6%。

IPDQF revenueIPDQF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09